Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Care Clinics vs Sprout Health

By GLP-1 ScorecardUpdated

Care Clinics
Site position #13

Higher grade

Sprout Health
Site position #26

Lower grade

Score comparison

Care Clinics has the higher recorded score — 85.4/100 to 79.8/100.

Care Clinics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The cheapest both-molecule pairing in the ranking ($100/$133) from a LegitScript-verified operator.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCare Clinics +4
94
90
Dose & formulationSprout Health +2
80
82
Clinical oversightCare Clinics +30
85
55
Labs & monitoringSprout Health +9
83
92
FulfillmentCare Clinics +2
80
78
Contract termsCare Clinics +2
86
84
Care Clinics · top barSprout Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCare ClinicsSprout Health
WeighScore85.4/10079.8/100
GradeBC+
Site position#13#26
Semaglutide$100/mo$149/4 weeks (main-site offer; confirm selected plan)
Tirzepatide$133/mo$199/4 weeks (main-site offer; confirm selected plan)
Coverage32 statesState exclusions in terms; confirm current eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Care Clinics

Site position #13 · B

Strengths

  • Lowest combined price ($100 sema / $133 tirz)
  • LegitScript-verified
  • Both molecules

What to consider

  • Only 32 states — not nationwide
  • Injection-only
  • Labs/monitoring not published
Sprout Health

Site position #26 · C+

FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.

Strengths

  • Main-site compounded injection plans list $149 semaglutide / $199 tirzepatide per four weeks
  • Evaluation, medication and shipping advertised as included
  • Current policy allows a full refund before pharmacy transmission, including after clinical review
  • Terms identify a clinical network and possible pharmacy contacts

What to consider

  • The $99/$149 annual equivalents require $1,188/$1,788 upfront; selected offer terms need confirmation
  • Four-week billing differs from calendar-month billing, and policy descriptions differ across plan types
  • Cancellation requires 48-hour billing notice; shipment pauses need five business days
  • Assigned clinician/pharmacy, state eligibility and current branded access remain unconfirmed
  • An order becomes nonrefundable after pharmacy transmission; follow FDA guidance for warm injectable shipments

Featured provider

Sprout Health

Sprout Health scores 79.8/100 (C+). Sprout advertises four-week compounded injection plans and separate annual prepayments; confirm the selected bill, pharmacy handoff and cancellation date.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard